| Issue Date | Title | Author(s) |
| 2014 | Comparison of ishage-based CD34 (+) cell enumeration protocols on BD facs canto ıı and attune flow cytometers | Kozanoğlu, İlknur; Ünver, Gülşah; Sarıtürk, Çağla; Baran, Yusuf ; Yeral, Mahmut; Boğa, Can; Özdoğu, Hakan |
| 2013 | Cytotoxic effects of apigenin on multiple myeloma cells | Baran, Yusuf ; Yılmaz, S. ; Cincin, Zeynep; Kozanoğlu, İlknur; Çakmakoğlu, Bedia; Özdoğu, Hakan |
| 2013 | Diagnostic and therapeutic potentials of expression levels of bioactive sphingolipid genes in newly diagnosed and drug-resistant chronic myeloid leukemia patients | Baran, Yusuf ; Yandım, Melis; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, Özden; Özcan, Mehmet Ali |
| 2015 | Discovering alternative targets in chronic myeloid leukemia (CML): determination of expression levels of bioactive sphingolipid genes in newly diagnosed and drug-resistant CML patients | Kartal Yandım, Melis; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, Özden; Özcan, Mehmet Ali; Baran, Yusuf |
| 2013 | Effects of apigenin on imatinin-sensitive and resistant chronic myeloid leukemia cells | Baran, Yusuf ; Solmaz, Soner; Gökbulut, Aysun ; Kozanoğlu, İlknur; Özdoğu, Hakan |
| 2014 | Expression levels of ceramide-generating and clearance genes in newly diagnosed and tyrosine kinase inhibitor-resistant chronic myeloid leukemia patients: An attempt to find novel targets | Kartal Yandım, Melis; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, Özden; Özcan, Mehmet Ali; Saydam, Güray; Baran, Yusuf |
| 2014 | Expression levels of ceramide-metabolising genes in newly diagnosed and tyrosine kinase inhibitor-resistant chronic myeloid leukemia (CML) patients: The discovery of novel targets in CML | Yandım, Melis Kartal; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, O.; Özcan, Mehmet Ali; Saydam, Göksel; Baran, Yusuf |
| 2015 | Expression levels of JAK/STAT signaling genes in newly diagnosed, drug sensitive and resistant chronic myeloid leukemia patients | Kiraz, Yağmur ; Saydam, Güray; Şahin, Fahri; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, Özden; Baran, Yusuf |
| 2013 | Immunologically detection of BCR/ABL fusion protein with flow cytometry in K562 chronic myeloid leukemia cells and comparison with RT-PCR results | Kozanoğlu, İlknur; Aygün, B.; Boğa, I.; Cansun, C.; Üstündağ, N.; Baran, Yusuf ; Özdoğu, Hakan |
| 2014 | JAK/STAT Signalling pathway genes in the regulation of tyrosine kinase inhibitors induced and clinical process in chronic myeloid leukemia patients | Kiraz, Yağmur ; Kartal Yandım, Melis; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, I.; Özcan, Mehmet Ali; Saydam, Göksel; Şahin, Fahri; Avcu, Ferit; Ural, Ali Uğur; Ünal, Ali; Baran, Yusuf |
| Feb-2013 | New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma | Kozanoğlu, İlknur; Kartal Yandım, Melis; Çinçin, Zeynep Birsu; Özdoğu, Hakan; Çakmakoğlu, Bedia; Baran, Yusuf |
| 2014 | A novel biomarker for drug resistance in chronic myeloid leukemia: MicroRNA-17 | Baran, Yusuf ; Fıratlıgil, Burcu ; Kartal Yandım, Melis; Kiraz, Yağmur ; Kozanoğlu, İlknur; Özdoğu, Hakan; Ünal, Ali |
| May-2014 | Therapeutic potential of apigenin, a plant flavonoid, for imatinib-sensitive and resistant chronic myeloid leukemia cells | Solmaz, Soner; Adan Gökbulut, Aysun ; Çinçin, Zeynep Birsu; Özdoğu, Hakan; Boğa, Can; Çakmakoğlu, Bedia; Kozanoğlu, İlknur; Baran, Yusuf |
